These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1452811)

  • 21. Infection of SCID mice with lactate dehydrogenase-elevating virus stimulates B-cell activation.
    Bradley DS; Broen JJ; Cafruny WA
    Viral Immunol; 1991; 4(1):59-70. PubMed ID: 1905935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of transplacental virus infection by developmental and immunological factors: studies with lactate dehydrogenase-elevating virus.
    Haven TR; Rowland RR; Plagemann PG; Wong GH; Bradley SE; Cafruny WA
    Virus Res; 1996 Apr; 41(2):153-61. PubMed ID: 8738174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of development of glomerulonephritis in NZB x NZWF1 mice by persistent infection with lactic dehydrogenase virus: relations between intercellular adhesion molecule-1 expression on endothelial cells and leucocyte accumulation in glomeruli.
    Kameyama Y; Hayashi T
    Int J Exp Pathol; 1994 Aug; 75(4):295-304. PubMed ID: 7947231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Replication of lactate dehydrogenase-elevating virus in cells infected with murine leukaemia viruses in vitro.
    Inada T; Yamazaki S
    J Gen Virol; 1991 Oct; 72 ( Pt 10)():2437-44. PubMed ID: 1655956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lactate dehydrogenase-elevating virus (LDV): lifelong coexistence of virus and LDV-specific immunity.
    van den Broek MF; Spörri R; Even C; Plagemann PG; Hänseler E; Hengartner H; Zinkernagel RM
    J Immunol; 1997 Aug; 159(4):1585-8. PubMed ID: 9257815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in antibody specificities and cytokine release after infection with lactate dehydrogenase-elevating virus.
    Aparicio JL; Saxena A; Coutelier JP; Van Snick J; Retegui LA
    Int Immunopharmacol; 2013 Mar; 15(3):544-9. PubMed ID: 23391715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lactate dehydrogenase-elevating virus induces antibodies reactive with a surface antigen of aetiologically unrelated murine cell transformants.
    Weiland E; Grossmann A; Thiel HJ; Weiland F
    J Gen Virol; 1990 May; 71 ( Pt 5)():1233-6. PubMed ID: 2345370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of plasma clearance rates and immune response by negative charges: lactic dehydrogenase isoenzymes in normal and LDV-infected mice.
    Wachsmuth ED; Klingmüller D
    J Reticuloendothel Soc; 1978 Sep; 24(3):227-41. PubMed ID: 731629
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of prostaglandin E2 on plasma lactic dehydrogenase activity in (NZB x NZW)F1 mice with a chronic infection of lactic dehydrogenase virus.
    Hayashi T
    J Comp Pathol; 1992 Jul; 107(1):41-8. PubMed ID: 1430347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection of C58 mice from lactate dehydrogenase-elevating virus-induced motor neuron disease by non-neutralizing antiviral antibodies without interference with virus replication.
    Harty JT; Chan SP; Contag CH; Plagemann PG
    J Neuroimmunol; 1987 Jun; 15(2):195-206. PubMed ID: 3034974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of various adjuvants and a viral infection on the antibody specificity toward native or cryptic epitopes of a protein antigen.
    Gómez KA; Longhi SA; Marino VJ; Mathieu PA; Loureiro ME; Coutelier JP; Roguin LP; Retegui LA
    Scand J Immunol; 2003 Feb; 57(2):144-50. PubMed ID: 12588660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infection of mice with lactate dehydrogenase-elevating virus leads to stimulation of autoantibodies.
    Cafruny WA; Hovinen DE
    J Gen Virol; 1988 Mar; 69 ( Pt 3)():723-9. PubMed ID: 2832535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of monoclonal antibodies to the lactate dehydrogenase-elevating virus.
    Harty JT; Chan SP; Plagemann PG
    Intervirology; 1987; 27(1):53-60. PubMed ID: 3610572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trojan Horse macrophages: studies with the murine lactate dehydrogenase-elevating virus and implications for sexually transmitted virus infection.
    Cafruny WA; Bradley SE
    J Gen Virol; 1996 Dec; 77 ( Pt 12)():3005-12. PubMed ID: 9000091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mouse Ia antigens are receptors for lactate dehydrogenase virus.
    Inada T; Mims CA
    Nature; 1984 May 3-9; 309(5963):59-61. PubMed ID: 6585645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lactate dehydrogenase-elevating virus infection at the sensitization and challenge phases reduces the development of delayed eosinophilic allergic rhinitis in BALB/c mice.
    Sasaki Y; Hayashi T; Hasegawa K
    Scand J Immunol; 2007 Dec; 66(6):628-35. PubMed ID: 17949409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lactic dehydrogenase virus (LDV) impairs the antigen-presenting capacity of macrophages yet fails to affect their phagocytic activity.
    Isakov N; Feldman M; Segal S
    Immunobiology; 1982; 162(1):15-27. PubMed ID: 7106838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The murine antibody response to lactate dehydrogenase-elevating virus.
    Coutelier JP; Van Roost E; Lambotte P; Van Snick J
    J Gen Virol; 1986 Jun; 67 ( Pt 6)():1099-108. PubMed ID: 3519860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in the specificity of antibodies in mice infected with lactate dehydrogenase-elevating virus.
    Gómez KA; Coutelier JP; Retegui LA
    Scand J Immunol; 1997 Aug; 46(2):168-74. PubMed ID: 9583997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neonatal infection of mice with lactate dehydrogenase-elevating virus results in suppression of humoral antiviral immune response but does not alter the course of viraemia or the polyclonal activation of B cells and immune complex formation.
    Rowland RR; Even C; Anderson GW; Chen Z; Hu B; Plagemann PG
    J Gen Virol; 1994 May; 75 ( Pt 5)():1071-81. PubMed ID: 8176369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.